Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression data from a Brazilian cohort of pediatric adrenocortical tumors

ABSTRACT: Gene expression data from a Brazilian cohort of pediatric adrenocortical tumors

PROVIDER: PRJNA754189 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression data from a Brazilian cohort of pediatric adrenocortical tumors

Project description:Adrenocortical tumors in children are rare, but 10-15 times more incident in Southern Brazil than in the rest of the world. However, reliable biomarkers capable of establishing a well-defined prognostic correlation or predicting relapse risk of the disease are still challenging. Herein, we aimed to compare the expression profiles of pediatric adrenocortical tumors of patients with favorable and unfavorable clinical outcomes.

2025-05-02 | GSE182022 | GEO

Gene expression data from a Brazilian cohort of pediatric medulloblastomas

Project description:Herein, we aimed to analyze the gene expression profile of medulloblastoma samples from a Brazilian cohort of 17 pediatric patients.

2024-01-10 | GSE181293 | GEO

microRNA expression profile of pediatric adrenocortical tumors

Project description:Here, we used a microarray technique to provide miRNA expression data of a set of 37 adrenocortical tumors (ACT) and 9 non-neoplastic adrenal controls from Brazilian patients assisted in two treatment centers in the state of São Paulo (HC-FMRP-USP and Centro Infantil Boldrini of Campinas).

2022-01-12 | GSE169253 | GEO

DNA Methylation Profiling Reveals Prognostically Significant Groups in Pediatric Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry

Project description:Pediatric adrenocortical carcinomas (ACCs) are aggressive; the overall survival of pediatric patients with ACCs is 40%-50%. Appropriate staging and histologic classification are crucial as children with incompletely resected tumors or metastatic disease have a dismal prognosis. The clinical course of pediatric adrenocortical tumors (ACTs) is difficult to predict using the current classification schemas, which rely heavily on subjective microscopic and gross macroscopic variables. Recent advances in adult ACT studies have revealed distinct DNA-methylation patterns with prognostic significance that have not been systematically interrogated in the pediatric population.

2020-05-16 | GSE131350 | GEO

microRNA expression profile of pediatric adrenocortical tumors

Project description:microRNA expression profile of pediatric adrenocortical tumors

| PRJNA715778 | ENA

SNP data from 13 childhood adrenocortical tumours from Brazilian patients and 6 matched normal samples

Project description:SNP array data from 13 Brazilian childhood adrenocortical tumors (ACTs) were analyzed to detect recurrent copy number changes and highlight potential candidate driver genes.

2012-03-23 | GSE24804 | GEO

Tumor DNA methylation profiling of pediatric patients with adrenocortical tumors

Project description:Abnormal DNA methylation contributes to tumor progression and is emerging as a prognostic marker in several types of cancers. To investigate whether DNA methylation is associated with Pediatric Adrenocortical Tumor (pACT) presentation and patient prognosis, we analyzed the methylation profile of 57 tumors (Illumina Infinium HumanMethylation850 BeadChip) and patients’ clinicopathological features and outcome.

2023-01-26 | GSE179175 | GEO

SNP data from 13 childhood adrenocortical tumours from Brazilian patients and 6 matched normal samples

Project description:SNP array data from 13 Brazilian childhood adrenocortical tumors (ACTs) were analyzed to detect recurrent copy number changes and highlight potential candidate driver genes. 13 childhood ACT were analyzed with Illumina HumanCNV370-Duo v1.0 chips. Paired normal blood samples from 6 patients were analyzed with Illumina HumanCNV370-Quad v3.0 chips.

2012-03-23 | E-GEOD-24804 | biostudies-arrayexpress

Gene expression data from a Brazilian cohort of pediatric medulloblastomas

Project description:Gene expression data from a Brazilian cohort of pediatric medulloblastomas

| PRJNA751489 | ENA

Gene exrpression profiling of childhood adrenocortical tumors

Project description:Pediatric adrenocortical tumors (ACT) are rare and often fatal malignancies; little is known regarding their etiology and biology. To provide additional insight into the nature of ACT, we determined the gene expression profiles of 24 pediatric tumors (five adenomas, 18 carcinomas, and one undetermined) and seven normal adrenal glands. Distinct patterns of gene expression, validated by quantitative real-time PCR and Western blot analysis, were identified that distinguish normal adrenal cortex from tumor. Differences in gene expression were also identified between adrenocortical adenomas and carcinomas. In addition, pediatric adrenocortical carcinomas were found to share similar patterns of gene expression when compared with those published for adult ACT. This study represents the first microarray analysis of childhood ACT. Our findings lay the groundwork for establishing gene expression profiles that may aid in the diagnosis and prognosis of pediatric ACT, and in the identification of signaling pathways that contribute to this disease. We used microarrays to explore the expression profiles differentially expressed in childhood adrenocortical tumors and in normal adrenal gland tissues. Pediatric adrenocortical adenoma and carcinoma patients were enrolled on the International Pediatric Adrenocortical Tumor Registry (IPACTR) and Bank protocol. Tumor specimens were harvested during surgery and snap frozen in liquid nitrogen to preserve tissue integrity. Data have been compiled for eight males and 15 females between 0 and 16 years of age. Table 1 (West et al, Cancer Research 67:601-608, 2007) summarizes the primary clinical information for each subject (excluding sample Unk1 with ACT of undetermined histology), including stage of the disease, tumor class, sex, age, relapse-free survival, and overall survival.

2015-11-25 | E-GEOD-75415 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data